Is mechanical clot removal or disruption a cost-effective treatment for acute stroke?

American Journal of Neuroradiology

Volumn 32, Issue 2, 2011, Pages 244-249

  Nguyen Huynh, Mai N ^a   Johnston, S C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOPLASTY; ARTERY OCCLUSION; ARTICLE; BLOOD CLOT; BRAIN ISCHEMIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FEMALE; HUMAN; MALE; META ANALYSIS (TOPIC); QUALITY ADJUSTED LIFE YEAR; RECANALIZATION; SENSITIVITY ANALYSIS;

ACUTE DISEASE; AGED; ANGIOPLASTY; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; MARKOV CHAINS; MODELS, ECONOMETRIC; QUALITY OF HEALTH CARE; STROKE; THROMBECTOMY;

EID: 79951632072     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2329     Document Type: Article

References (29)

1. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-38. Epub 2005 Jun 16 (Pubitemid 40967507)
2. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke: results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-82 (Pubitemid 44897621)
3. Bose A, Henkes H, Alfke K, et al. The Penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409-13
4. Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-87
5. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke: NINDS rt-PA Stroke Study Group. Neurology 1998;50:883-90 (Pubitemid 28212810)
6. Patil CG, Long EF, Lansberg MG. Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke. J Neurosurg 2009;110:508-13
7. Hills NK, Johnston SC. Why are eligible thrombolysis candidates left untreated? Am J Prev Med 2006;31:S210-16
8. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29
9. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-73 (Pubitemid 46568460)
10. Flint AC, Duckwiler GR, Budzik RF, et al. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007;38:1274-80. Epub 2007 Mar 1 (Pubitemid 351664267)
11. Barnwell SL, Clark WM, Nguyen TT, et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817-22 (Pubitemid 24352825)
12. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12 (Pubitemid 351440692)
13. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in Health and Medicine. New York: Oxford University Press; 1996
14. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups - the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711. Epub 2007 Apr 12 (Pubitemid 46691097)
15. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study - a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
16. Department of Health and Human Services. Centers for Medicare & Medicaid Services. Changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates. Federal Register 73:48433-9084. http://www.access.gpo.gov/su-docs/fedreg/a080819c.html. Published August 19, 2008. Accessed October 12, 2009
17. Kent D, KuntzKM,Patel MR, et al. Perioperative imaging strategies for carotid endarterectomy: an analysis of morbidity and cost-effectiveness in symptomatic patients. JAMA 1995;274:888-94
18. EckmanMH,Rosand J, Knudsen KA, et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003;34:1710-16 (Pubitemid 36842632)
19. Earnshaw SR, Joshi AV, Wilson MR, et al. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke 2006;37:2751-58. Epub 2006 Sep 28 (Pubitemid 44929415)
20. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146:473-81
21. Yasaka M, O'Keefe GJ, Chambers BR, et al. Streptokinase in acute stroke: effect on reperfusion and recanalization - Australian Streptokinase Trial study group. Neurology 1998;50:626-32
22. Kuntz KM, Kent KC. Is carotid endarterectomy cost-effective? An analysis of symptomatic and asymptomatic patients. Circulation 1996;94:II194-198
23. Johnston SC, Gress DR, Kahn JG. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology 1999;52:1806-15 (Pubitemid 29260893)
24. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976-82
25. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke - PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11 (Pubitemid 28046933)
26. Molina CA, Montaner J, Abilleira S, et al. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study. Stroke 2001;32:2821-27 (Pubitemid 33134472)
27. Cintas P, Le Traon AP, Larrue V. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke 2002;33:626-28 (Pubitemid 34123418)
28. Rother J, Schellinger PD, Gass A, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke 6 hours. Stroke 2002;33:2438-45
29. Gage BF, Cardinalli AB, Albers GW, et al. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 1995;274:1839-45 (Pubitemid 26001259)